Zhou Zun Qiang, Kim Song Cheol, Song Ki Byung, Park Kwang-Min, Lee Jae Hoon, Lee Young-Joo
Department of Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China,
World J Surg. 2014 Nov;38(11):2973-9. doi: 10.1007/s00268-014-2671-3.
Spleen-preserving laparoscopic distal pancreatectomy (SPLDP) can be performed with splenic vessel resection (SVR) or splenic vessel preservation (SVP). The purpose of this comparative study was to evaluate the clinical outcomes of patients who underwent SPLDP with SVR or SVP at a single institution.
We retrospectively reviewed the records of 246 patients who underwent SPLDP at Asan Medical Center, Seoul, Korea, for benign or low-grade malignant tumors found in the body or tail of the pancreas between November 2005 and November 2011.
In total, 206 patients (83.7 %) were managed by SVP. SVR was performed in the remaining 40 (16.3 %) cases. There were no significant differences between the SVP and SVR groups in terms of intraoperative blood loss (378 ± 240 vs. 328 ± 204 ml, respectively; P = 0.240) and operating time (193.4 ± 59.1 vs. 204.4 ± 51.8 min, respectively; P = 0.492). Sixty-seven (32.5 %) and 10 patients (25 %) had complications in the SVP and SVR groups, respectively (P = 0.347). At 3 days after surgery, the rates of splenic infarction were 16.0 % (33/206) in the SVP group and 52.5 % (21/40) in the SVR group, but all recovered within 12 months on postoperative computed tomography. The time of recovery from splenic infarction was 3.6 ± 3.1 and 4.7 ± 3.7 months in the SVP and SVR groups, respectively. At 6 months, the rates of gastric varices were 1.9 % in the SVP group and 35 % in the SVR group (P < 0.001) with no progression at 12 months. No gastrointestinal bleeding occurred at a median follow-up of 34 months (range = 12-84).
SPLDP with SVR can be used for patients with large and benign or low-grade malignant tumors that distort and compress vessel course, as the higher rate of early splenic ischemia and perigastric varices is acceptable.
保留脾脏的腹腔镜远端胰腺切除术(SPLDP)可在切除脾血管(SVR)或保留脾血管(SVP)的情况下进行。本对比研究的目的是评估在单一机构接受SVR或SVP的SPLDP患者的临床结局。
我们回顾性分析了2005年11月至2011年11月期间在韩国首尔峨山医学中心接受SPLDP治疗胰腺体尾部良性或低度恶性肿瘤的246例患者的记录。
总共206例患者(83.7%)接受了SVP治疗。其余40例(16.3%)进行了SVR。SVP组和SVR组在术中失血量(分别为378±240 ml和328±204 ml;P = 0.240)和手术时间(分别为193.4±59.1分钟和204.4±51.8分钟;P = 0.492)方面无显著差异。SVP组和SVR组分别有67例(32.5%)和10例(25%)出现并发症(P = 0.347)。术后3天,SVP组脾梗死发生率为16.0%(33/206),SVR组为52.5%(21/40),但术后计算机断层扫描显示所有患者均在12个月内恢复。SVP组和SVR组从脾梗死恢复的时间分别为3.6±3.1个月和4.7±3.7个月。6个月时,SVP组胃静脉曲张发生率为1.9%,SVR组为35%(P < 0.001),12个月时无进展。在34个月的中位随访期(范围 = 12 - 84个月)内未发生胃肠道出血。
对于肿瘤大且为良性或低度恶性、扭曲并压迫血管走行的患者,可采用SVR的SPLDP,因为早期脾缺血和胃周静脉曲张的较高发生率是可以接受的。